TAAR1 has been shown to play an important role in modulating monoaminergic neurotransmission, particularly in relation to psychostimulants and addiction, and TAAR1 agonists are increasingly recognized as a novel mechanism for treatment of psychiatric disorders [20,45,46,47]. The gene discussed is TAAR1; the disease is psychiatric disorder.